A randomized phase <scp>I</scp> study of methanesulfonyl fluoride, an irreversible cholinesterase inhibitor, for the treatment of <scp>A</scp>lzheimer's disease
BJCP. British journal of clinical pharmacology/British journal of clinical pharmacology